JUMPCAN(SH:600566) Sou Hu Cai Jing·2025-06-28 17:38Core Viewpoint - Hubei Jichuan Pharmaceutical Co., Ltd. announced a cash dividend of 2.09 RMB per share as part of its 2024 annual profit distribution plan, with the record date set for June 27, 2025 [1][2] Company Announcements - The company reported a total market capitalization of 26.702 billion RMB, ranking 7th in the traditional Chinese medicine sector and 566th among all A-shares [1] - The cash dividend distribution will total approximately 1.921 billion RMB, based on 919,349,675 shares [1] - The offer price for the company's buyback will be adjusted from 48 RMB to 45.92 RMB per share, effective June 30, 2025 [2][3] - The adjusted offer price for the share buyback is set at 24.85 RMB per share due to the annual profit distribution [1][3] Dividend Taxation - For individual shareholders holding shares for over one year, the dividend income is exempt from personal income tax, resulting in a net cash dividend of 2.09 RMB per share [1] - For qualified foreign institutional investors (QFII), a 10% corporate income tax will be withheld, leading to a net cash dividend of 1.881 RMB per share [1] - Other institutional investors are responsible for their own tax payments, receiving a net cash dividend of 2.09 RMB per share [1]